Sensipar, a new drug for dialysis patients

You'll hear about Sensipar, a new drug for dialysis patients.

Chronic kidney disease usually leads to LOW vitamin D... LOW serum calcium...HIGH serum phosphate...and HYPERparathyroidism.

Patients usually get phosphate binders and vitamin D analogues, but these can also throw off calcium and phosphate.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote